← All trials
NCT03050476
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 1, 2017
- Primary completion
- Feb 1, 2019
- Completion date
- Feb 1, 2022
- First posted
- —
- Last posted
- —
- Enrollment
- 1050
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Alloksys Life Sciences B.V.Lead sponsor
- National University of SingaporeOverall official - principal investigator
- Singapore Clinical Research InstituteCollaborator
- Aix ScientificsCollaborator
- Alloksys Life Sciences B.V.Study chair
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.